In recent decades, there has been a growing focus on the management and valorization of digestate, primarily driven by its nutrient-rich composition, which positions it as a promising resource for biofertilizer production. However, several countries still restrict the direct application of digestate due to its potential environmental hazard, which includes the presence of contaminants of emerging concern (CECs) such as pharmaceuticals. This paper explores the efficacy of a novel UV/ozone-based technology, UVOX Redox®, in removing prevalent pharmaceuticals, including antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs), from the digestate of two biogas plants. In both cases, UVOX showed to be a feasible solution for pharmaceutical removal from digestate. Addition of hydrogen peroxide further increased the process efficiency, achieving > 90% removal of all compounds within an hour. The energy per order (E_EO) value for all the studied pharmaceuticals was less than the reported median E_EO for O₃ and UV treatment, showcasing notable energy efficiency in UVOX technology. Moreover, the research highlights that the presence of ions augments the removal efficiency when applying the UVOX technology. In addition, the research results revealed a significant correlation between the effectiveness of the UVOX technology and UV transmittance, with R² exceeding 90% for pharmaceuticals and 75% for Dissolved Organic Carbon (DOC). This finding suggests that UV transmittance can serve as a viable surrogate method for implementing this advanced oxidation process in practical applications.

P-limitation in enhanced biological phosphorus removal (EBPR) systems fed with acetate, has generally been considered as a condition leading to enrichment of organisms of the genotype’ Candidatus Competibacter phosphatis’ expressing the glycogen-accumulating organisms (GAO) phenotype. Recent studies have demonstrated in short-term experiments that organisms of the genotype ‘Candidatus Accumulibacter phosphatis’ clade I and II, known to express the polyphosphate-accumulating organisms (PAO) phenotype can switch to the GAO phenotype when poly-P is absent, but are performing the HAc-uptake at lower kinetic rates, where clade I showed the lowest rates. The objective of this study was to verify whether organisms of the genotype ‘Candidatus Accumulibacter phosphatis’ can also be enriched under P-limiting conditions while expressing a GAO phenotype and more specifically to see which specific clade prevails. A sequencing batch reactor was inoculated with activated sludge to enrich an EBPR culture for a cultivation period of 128 days (16 times the solids retention time) under P-limiting conditions. A mixed culture was obtained comprising of 49 % ‘Candidatus Accumulibacter phosphatis’ clade II and 46 % ‘Candidatus Competibacter phosphatis’. The culture performed a full GAO metabolism for anaerobic HAc-uptake, but was still able to switch to a PAO metabolism, taking up excessive amounts of phosphate during the aerobic phase when it became available in the influent. These findings show that P-limitation, often used as strategy for enrichment of ‘Candidatus Competibacter phosphatis’, does not always lead to enrichment of only ‘Candidatus Competibacter phosphatis’. Furthermore, it demonstrates that ‘Candidatus Accumulibacter phosphatis’ are able to proliferate in activated sludge systems for periods of up to 128 days or longer when the influent phosphate concentrations are just enough for assimilation purposes and no poly-P is formed. The ‘Candidatus Accumulibacter phosphatis’ retain the ability to switch to the PAO phenotype, taking up phosphate from the influent as soon as it becomes available.